CLINICAL_TRIALS
trial_result
· 2014-06-24
Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes
Summary
A completed observational study evaluating the safety and efficacy of NovoMix 70 in people with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED